lorcaserin Belviq withdrawn
Selected indexed studies
- Lorcaserin. (, 2012) [PMID:31644141]
- Weight Loss Agents. (, 2012) [PMID:31644235]
- Why are anti-obesity drugs stigmatized? (Expert Opin Drug Saf, 2015) [PMID:25529104]
_Worker-drafted node — pending editorial review._
Connections
lorcaserin Belviq withdrawn is a side effect of
Sources
- Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine? (2022) pubmed
- Lorcaserin. (2012) pubmed
- Weight Loss Agents. (2012) pubmed
- Why are anti-obesity drugs stigmatized? (2015) pubmed
- Pharmacotherapy of obesity: An update. (2021) pubmed
- Role of serotonin 5HT 2C receptors in the discriminative stimulus properties of lorcaserin in male C57BL/6 mice. (2025) pubmed
- Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice. (2024) pubmed
- Serotonin in the regulation of systemic energy metabolism. (2022) pubmed
- Long-term effects of weight-reducing drugs in people with hypertension. (2016) pubmed
- Past, present and future of pharmacotherapy for obesity. (2017) pubmed